26095-36-3 Usage
General Description
5-Morpholin-4-ylmethyl-furan-2-carboxylic acid is a chemical compound with potential pharmaceutical applications. It is a furan carboxylic acid derivative that contains a morpholine substituent. 5-Morpholin-4-ylmethyl-furan-2-carboxylic acid has shown promising antifungal and antibacterial activity in studies, making it a potential candidate for the development of new drugs to combat infectious diseases. Additionally, its furan ring structure suggests potential for use in the synthesis of other biologically active compounds. Further research and development of 5-Morpholin-4-ylmethyl-furan-2-carboxylic acid could lead to the discovery of valuable drug candidates with therapeutic potential.
Check Digit Verification of cas no
The CAS Registry Mumber 26095-36-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,6,0,9 and 5 respectively; the second part has 2 digits, 3 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 26095-36:
(7*2)+(6*6)+(5*0)+(4*9)+(3*5)+(2*3)+(1*6)=113
113 % 10 = 3
So 26095-36-3 is a valid CAS Registry Number.
InChI:InChI=1/C10H13NO4/c12-10(13)9-2-1-8(15-9)7-11-3-5-14-6-4-11/h1-2H,3-7H2,(H,12,13)
26095-36-3Relevant articles and documents
Benzothiazole compounds and medical application
-
Paragraph 0220; 0024; 0230, (2020/10/21)
The invention discloses a benzothiazole compound and medical application thereof, particularly relates to a benzothiazole compound shown as a formula I and medical application thereof, and especiallyrelates to application of the benzothiazole compound serving as a USP7C-terminal structural domain regulating agent in medicines for preventing and treating myelodysplastic syndromes and malignant tumors. The benzothiazole compound shown in the formula I or the pharmaceutically acceptable salt or solvate of the benzothiazole compound has strong binding force with USP7C-terminal protein; and the protein level of DNMT1 in tumor cells can be reduced, so that the compound can be applied to the preparation of USP7 regulators, has a remarkable anti-tumor cell proliferation effect, and can be used for preparing medicines for preventing or treating myelodysplastic syndrome and malignant tumors.
